Ongoing Laboratory Monitoring During Treatment During the maintenance phase, laboratory tests may be repeated every six to twelve months depending on the patients medication regimen, overall health, and clinical progression
Barros PGM LiJTremblayCOkadaMYSznejderHFurlanVet al
Each batch undergoes third-party testing and mass spectrometry (MS) verification to confirm identity and structural integrity
However, Ozempic itself remains approved primarily for managing blood glucose levels in patients with type 2 diabetes, and it is not officially indicated for weight loss in non-diabetic individuals
This can occur through mechanisms such as slowing carbohydrate absorption, improving insulin sensitivity, interacting with other satiety hormones or via the microbiome
Acknowledgements Our work was supported by the life insurance company AG2R-La-Mondiale, the Agence Nationale de la Recherche (ANR 21 CE15-003-02 BRAINITY, ANR 21 CE37 0030 02 EMOKET) and the Laboratoire dExcellence Revive (Investissement dAvenir, ANR-10-LABX-73)